Biotechnology
The Biotechnology industry has a total of 626 stocks, with a combined market cap of $911.94 billion and total revenue of $101.57 billion.
Market Cap
911.94B
Revenue
101.57B
Profits
-42.48B
PE Ratio
n/a
Profit Margin
-41.82%
Dividend Yield
0.05%
626 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 102.81B | 2.55% | 1,859,189 | 11.42B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 59.92B | -0.48% | 1,020,210 | 14.21B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 58.59B | 0.11% | 1,063,216 | 2.46B |
| 4 | ARGX | argenx SE | 43.25B | -0.81% | 348,851 | 3.12B |
| 5 | ONC | BeOne Medicines AG | 36.53B | 8.49% | 766,076 | 4.56B |
| 6 | INSM | Insmed Incorporated | 30.71B | 6.76% | 4,855,110 | 398.11M |
| 7 | BNTX | BioNTech SE | 24.19B | 0.62% | 784,382 | 3.38B |
| 8 | RPRX | Royalty Pharma plc | 21.09B | 0.53% | 4,472,703 | 2.31B |
| 9 | SMMT | Summit Therapeutics Inc. | 17.71B | 0.59% | 1,812,130 | - |
| 10 | INCY | Incyte Corporation | 16.79B | 1.62% | 2,205,614 | 4.58B |
| 11 | GMAB | Genmab A/S | 15.88B | 4.10% | 2,117,287 | 3.65B |
| 12 | ASND | Ascendis Pharma A/S | 12.06B | 2.52% | 561,522 | 576.33M |
| 13 | BMRN | BioMarin Pharmaceutical Inc. | 11.35B | 1.41% | 1,716,111 | 3.06B |
| 14 | CAI | Caris Life Sciences, Inc. | 10.28B | -4.77% | 423,706 | 533.85M |
| 15 | EXEL | Exelixis, Inc. | 10.01B | -0.64% | 4,089,499 | 2.23B |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.72B | -0.40% | 428,116 | 515.55M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 9.56B | -3.40% | 3,103,121 | 235.81M |
| 18 | MRNA | Moderna, Inc. | 9.41B | 0.42% | 14,227,702 | 3.08B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 9.16B | 34.83% | 16,461,052 | 944.05M |
| 20 | VRNA | Verona Pharma plc | 9.14B | 0.18% | 1,884,639 | 221.67M |
| 21 | HALO | Halozyme Therapeutics, Inc. | 8.58B | 0.26% | 2,678,172 | 1.18B |
| 22 | ROIV | Roivant Sciences Ltd. | 8.46B | 3.86% | 8,966,289 | 23.23M |
| 23 | TECH | Bio-Techne Corporation | 8.31B | -2.21% | 1,730,248 | 1.22B |
| 24 | JAZZ | Jazz Pharmaceuticals plc | 7.87B | 1.50% | 864,220 | 4.09B |
| 25 | CORT | Corcept Therapeutics Incorporated | 7.52B | 2.38% | 806,329 | 716.08M |
| 26 | RVMD | Revolution Medicines, Inc. | 7.39B | 4.11% | 2,524,381 | - |
| 27 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.92B | 1.03% | 754,699 | 156.29M |
| 28 | LEGN | Legend Biotech Corporation | 6.32B | -1.47% | 562,456 | 796.84M |
| 29 | AXSM | Axsome Therapeutics, Inc. | 6.16B | 1.81% | 902,682 | 495.03M |
| 30 | ABVX | ABIVAX Société Anonyme | 6.08B | 1.18% | 592,455 | 11.44M |
| 31 | RNA | Avidity Biosciences, Inc. | 6.08B | 1.40% | 3,032,257 | 10.73M |
| 32 | CYTK | Cytokinetics, Incorporated | 5.94B | 40.45% | 13,130,509 | 85.74M |
| 33 | NUVL | Nuvalent, Inc. | 5.54B | 0.42% | 565,741 | - |
| 34 | MRUS | Merus N.V. | 5.01B | 0.68% | 704,541 | 56.23M |
| 35 | CRSP | CRISPR Therapeutics AG | 4.79B | 1.60% | 1,494,303 | 38.05M |
| 36 | TGTX | TG Therapeutics, Inc. | 4.34B | 1.36% | 2,023,314 | 454.07M |
| 37 | ACAD | ACADIA Pharmaceuticals Inc. | 4.33B | -1.15% | 2,245,377 | 1.02B |
| 38 | KRYS | Krystal Biotech, Inc. | 4.31B | 0.88% | 317,181 | 359.21M |
| 39 | PTCT | PTC Therapeutics, Inc. | 4.16B | 6.28% | 1,780,939 | 1.76B |
| 40 | ADMA | ADMA Biologics, Inc. | 4.10B | -0.35% | 4,276,601 | 474.17M |
| 41 | PCVX | Vaxcyte, Inc. | 4.10B | 2.47% | 1,848,664 | - |
| 42 | ACLX | Arcellx, Inc. | 3.87B | 0.53% | 544,755 | 56.98M |
| 43 | AAPG | Ascentage Pharma Group International | 3.86B | -1.53% | 14,085 | 54.52M |
| 44 | MTSR | Metsera, Inc. | 3.80B | 2.61% | 1,298,912 | - |
| 45 | MIRM | Mirum Pharmaceuticals, Inc. | 3.73B | 0.64% | 920,845 | 429.16M |
| 46 | MLTX | MoonLake Immunotherapeutics | 3.72B | 5.04% | 677,437 | - |
| 47 | ZLAB | Zai Lab Limited | 3.71B | 0.73% | 554,125 | 427.80M |
| 48 | PTGX | Protagonist Therapeutics, Inc. | 3.66B | -0.34% | 665,841 | 209.18M |
| 49 | AKRO | Akero Therapeutics, Inc. | 3.63B | -2.76% | 797,802 | - |
| 50 | SLNO | Soleno Therapeutics, Inc. | 3.57B | -0.66% | 1,254,540 | 32.66M |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | 3.56B | 2.18% | 1,919,981 | 754.65M |
| 52 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.55B | 16.57% | 6,168,719 | 572.98M |
| 53 | SRRK | Scholar Rock Holding Corporation | 3.18B | 1.44% | 1,616,174 | - |
| 54 | TLX | Telix Pharmaceuticals Limited | 3.16B | -1.26% | 282,335 | 664.23M |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.14B | 7.45% | 1,464,495 | 1.39M |
| 56 | VKTX | Viking Therapeutics, Inc. | 3.09B | 1.63% | 4,700,521 | - |
| 57 | RARE | Ultragenyx Pharmaceutical Inc. | 3.08B | 6.91% | 2,012,204 | 610.16M |
| 58 | XENE | Xenon Pharmaceuticals Inc. | 3.03B | 1.52% | 622,799 | 7.50M |
| 59 | KYMR | Kymera Therapeutics, Inc. | 2.90B | -1.44% | 1,248,732 | 44.71M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 2.77B | 2.41% | 500,331 | 64.01M |
| 61 | IMVT | Immunovant, Inc. | 2.63B | 2.59% | 1,338,177 | - |
| 62 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.51B | -0.24% | 1,499,025 | 558.50M |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 2.47B | 0.02% | 859,387 | 295.52M |
| 64 | LQDA | Liquidia Corporation | 2.46B | 3.25% | 3,972,686 | 19.32M |
| 65 | FOLD | Amicus Therapeutics, Inc. | 2.43B | 3.82% | 4,551,102 | 571.16M |
| 66 | CNTA | Centessa Pharmaceuticals plc | 2.32B | 2.86% | 758,815 | 15.00M |
| 67 | AGIO | Agios Pharmaceuticals, Inc. | 2.28B | 4.08% | 630,183 | 40.88M |
| 68 | CELC | Celcuity Inc. | 2.27B | 4.59% | 576,592 | - |
| 69 | DNLI | Denali Therapeutics Inc. | 2.26B | 1.18% | 5,356,180 | - |
| 70 | IBRX | ImmunityBio, Inc. | 2.25B | 1.71% | 8,459,514 | 56.60M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.23B | 3.79% | 2,480,962 | 7.00M |
| 72 | APGE | Apogee Therapeutics, Inc. | 2.22B | 4.10% | 364,358 | - |
| 73 | OCUL | Ocular Therapeutix, Inc. | 2.21B | 4.01% | 2,789,274 | 56.66M |
| 74 | BLTE | Belite Bio, Inc | 2.14B | 3.28% | 18,414 | - |
| 75 | IRON | Disc Medicine, Inc. | 2.13B | 3.24% | 355,765 | - |
| 76 | HRMY | Harmony Biosciences Holdings, Inc. | 2.13B | 0.57% | 816,183 | 772.53M |
| 77 | CGON | CG Oncology, Inc. | 2.09B | 2.39% | 463,058 | 551.00K |
| 78 | GLPG | Galapagos NV | 2.07B | -0.92% | 138,053 | 323.67M |
| 79 | RXRX | Recursion Pharmaceuticals, Inc. | 2.04B | -0.85% | 12,478,690 | 64.60M |
| 80 | ADPT | Adaptive Biotechnologies Corporation | 1.96B | -2.58% | 1,354,105 | 205.22M |
| 81 | DYN | Dyne Therapeutics, Inc. | 1.92B | 0.11% | 3,087,915 | - |
| 82 | MLYS | Mineralys Therapeutics, Inc. | 1.91B | 86.43% | 15,718,293 | - |
| 83 | ARQT | Arcutis Biotherapeutics, Inc. | 1.84B | -1.29% | 1,167,314 | 263.47M |
| 84 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | -0.22% | 6,394,143 | 2.48B |
| 85 | MNKD | MannKind Corporation | 1.76B | 25.05% | 27,717,443 | 301.74M |
| 86 | VCEL | Vericel Corporation | 1.75B | -4.84% | 549,244 | 249.12M |
| 87 | MESO | Mesoblast Limited | 1.69B | -5.13% | 334,928 | 17.20M |
| 88 | BHVN | Biohaven Ltd. | 1.68B | 3.25% | 1,450,455 | - |
| 89 | COGT | Cogent Biosciences, Inc. | 1.68B | -0.66% | 1,354,250 | - |
| 90 | PHVS | Pharvaris N.V. | 1.63B | 3.93% | 141,713 | - |
| 91 | IMCR | Immunocore Holdings plc | 1.62B | 0.06% | 238,128 | 356.15M |
| 92 | TVTX | Travere Therapeutics, Inc. | 1.62B | 3.71% | 2,150,612 | 333.87M |
| 93 | CDTX | Cidara Therapeutics, Inc. | 1.62B | -2.45% | 525,687 | 302.00K |
| 94 | BEAM | Beam Therapeutics Inc. | 1.60B | -0.31% | 1,646,862 | 60.27M |
| 95 | VRDN | Viridian Therapeutics, Inc. | 1.56B | 4.19% | 1,491,603 | 305.00K |
| 96 | EWTX | Edgewise Therapeutics, Inc. | 1.56B | 3.21% | 1,048,067 | - |
| 97 | ARDX | Ardelyx, Inc. | 1.54B | 0.63% | 3,596,496 | 386.15M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.54B | -2.63% | 1,620,497 | 260.11M |
| 99 | WVE | Wave Life Sciences Ltd. | 1.53B | 0.21% | 1,130,647 | 93.95M |
| 100 | CLDX | Celldex Therapeutics, Inc. | 1.46B | -0.02% | 1,857,575 | 5.79M |
| 101 | VERA | Vera Therapeutics, Inc. | 1.44B | 4.48% | 2,387,371 | - |
| 102 | PGEN | Precigen, Inc. | 1.42B | 5.54% | 9,873,777 | 4.34M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 1.39B | -1.35% | 1,800,094 | 77.93M |
| 104 | JANX | Janux Therapeutics, Inc. | 1.37B | 0.53% | 900,171 | 439.00K |
| 105 | ETNB | 89bio, Inc. | 1.36B | 1.77% | 1,238,457 | - |
| 106 | INVA | Innoviva, Inc. | 1.32B | 2.20% | 881,361 | 370.23M |
| 107 | XERS | Xeris Biopharma Holdings, Inc. | 1.28B | 1.15% | 2,026,041 | 246.03M |
| 108 | ELVN | Enliven Therapeutics, Inc. | 1.24B | 3.06% | 355,046 | - |
| 109 | NVAX | Novavax, Inc. | 1.23B | 1.07% | 5,642,360 | 1.08B |
| 110 | NTLA | Intellia Therapeutics, Inc. | 1.22B | 0.35% | 3,459,318 | 52.86M |
| 111 | ABCL | AbCellera Biologics Inc. | 1.21B | -3.11% | 3,632,383 | 32.88M |
| 112 | CVAC | CureVac N.V. | 1.21B | - | 493,982 | 599.54M |
| 113 | QURE | uniQure N.V. | 1.16B | 4.16% | 1,198,132 | 14.34M |
| 114 | GPCR | Structure Therapeutics Inc. | 1.16B | 4.04% | 808,140 | - |
| 115 | RCUS | Arcus Biosciences, Inc. | 1.15B | 2.08% | 534,909 | 262.00M |
| 116 | LENZ | LENZ Therapeutics, Inc. | 1.12B | 1.60% | 327,637 | 5.00M |
| 117 | SION | Sionna Therapeutics, Inc. | 1.11B | 2.19% | 178,682 | - |
| 118 | SPRY | ARS Pharmaceuticals, Inc. | 1.10B | -4.30% | 4,875,588 | 112.34M |
| 119 | CRMD | CorMedix Inc. | 1.09B | -1.28% | 26,883,320 | 121.48M |
| 120 | UPB | Upstream Bio, Inc. | 1.09B | 18.27% | 2,191,653 | 2.72M |
| 121 | STOK | Stoke Therapeutics, Inc. | 1.07B | -0.86% | 986,260 | 199.89M |
| 122 | MDXG | MiMedx Group, Inc. | 1.06B | 1.13% | 421,822 | 363.77M |
| 123 | ZYME | Zymeworks Inc. | 1.05B | -5.44% | 562,503 | 122.87M |
| 124 | NUVB | Nuvation Bio Inc. | 1.01B | -0.67% | 3,086,365 | 14.36M |
| 125 | ORIC | ORIC Pharmaceuticals, Inc. | 1.01B | 1.37% | 1,041,795 | - |
| 126 | SYRE | Spyre Therapeutics, Inc. | 1.00B | 0.85% | 430,782 | - |
| 127 | ATAI | Atai Life Sciences N.V. | 983.81M | 0.22% | 3,268,950 | 2.31M |
| 128 | PHAR | Pharming Group N.V. | 960.29M | -5.94% | 9,130 | 339.84M |
| 129 | PRAX | Praxis Precision Medicines, Inc. | 941.27M | -1.79% | 439,193 | 7.77M |
| 130 | GERN | Geron Corporation | 937.89M | 5.00% | 11,797,288 | 164.45M |
| 131 | FTRE | Fortrea Holdings Inc. | 908.91M | 1.62% | 1,640,443 | 2.73B |
| 132 | URGN | UroGen Pharma Ltd. | 903.54M | 0.41% | 1,128,347 | 94.24M |
| 133 | AMLX | Amylyx Pharmaceuticals, Inc. | 889.89M | 6.40% | 2,665,856 | -249.00K |
| 134 | TRVI | Trevi Therapeutics, Inc. | 885.32M | 0.14% | 1,781,343 | - |
| 135 | GHRS | GH Research PLC | 864.07M | 3.19% | 107,395 | - |
| 136 | OCS | Oculis Holding AG | 847.32M | 0.37% | 19,463 | 960.67K |
| 137 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 828.19M | 7.16% | 220,253 | - |
| 138 | PHAT | Phathom Pharmaceuticals, Inc. | 825.33M | -2.71% | 1,195,255 | 114.04M |
| 139 | AVXL | Anavex Life Sciences Corp. | 814.27M | -1.66% | 950,959 | - |
| 140 | IMNM | Immunome, Inc. | 807.78M | -2.42% | 568,826 | 12.59M |
| 141 | AVBP | ArriVent BioPharma, Inc. | 804.89M | 3.77% | 346,343 | - |
| 142 | IOVA | Iovance Biotherapeutics, Inc. | 792.46M | -1.79% | 8,745,582 | 241.53M |
| 143 | NAGE | Niagen Bioscience, Inc. | 789.61M | -0.20% | 613,221 | 116.30M |
| 144 | TSHA | Taysha Gene Therapies, Inc. | 774.74M | -2.74% | 2,362,975 | 8.10M |
| 145 | DNTH | Dianthus Therapeutics, Inc. | 767.69M | 0.47% | 207,737 | 4.85M |
| 146 | DAWN | Day One Biopharmaceuticals, Inc. | 758.00M | -1.46% | 1,018,102 | 187.64M |
| 147 | SANA | Sana Biotechnology, Inc. | 744.25M | -7.19% | 4,435,978 | - |
| 148 | TNGX | Tango Therapeutics, Inc. | 740.99M | -0.75% | 689,377 | 24.30M |
| 149 | ZBIO | Zenas BioPharma, Inc. | 737.77M | 9.50% | 337,808 | 15.00M |
| 150 | ABUS | Arbutus Biopharma Corporation | 732.29M | 2.96% | 2,650,004 | 15.42M |
| 151 | IVA | Inventiva S.A. | 729.92M | -15.02% | 179,299 | 14.59M |
| 152 | KALV | KalVista Pharmaceuticals, Inc. | 719.36M | 6.17% | 1,140,261 | - |
| 153 | GYRE | Gyre Therapeutics, Inc. | 700.27M | -0.39% | 82,208 | 102.19M |
| 154 | SVRA | Savara Inc. | 697.38M | 0.91% | 2,186,973 | - |
| 155 | TBPH | Theravance Biopharma, Inc. | 697.00M | -0.29% | 877,898 | 77.21M |
| 156 | VALN | Valneva SE | 696.45M | -1.92% | 147,173 | 230.57M |
| 157 | NRIX | Nurix Therapeutics, Inc. | 696.45M | -2.46% | 1,225,471 | 88.38M |
| 158 | MNMD | Mind Medicine (MindMed) Inc. | 694.68M | 2.82% | 1,007,240 | - |
| 159 | VIR | Vir Biotechnology, Inc. | 694.58M | 1.21% | 1,322,276 | 19.00M |
| 160 | KURA | Kura Oncology, Inc. | 690.04M | 0.63% | 1,863,813 | 83.28M |
| 161 | RIGL | Rigel Pharmaceuticals, Inc. | 689.87M | -1.00% | 401,261 | 267.92M |
| 162 | PROK | ProKidney Corp. | 676.85M | -2.54% | 1,252,527 | 527.00K |
| 163 | MAZE | Maze Therapeutics, Inc. | 671.80M | 5.73% | 513,701 | 2.50M |
| 164 | TYRA | Tyra Biosciences, Inc. | 667.81M | -1.10% | 420,062 | - |
| 165 | TERN | Terns Pharmaceuticals, Inc. | 661.58M | 8.62% | 1,895,162 | - |
| 166 | IMTX | Immatics N.V. | 649.13M | 5.01% | 1,614,719 | 152.82M |
| 167 | BCAX | Bicara Therapeutics Inc. | 647.66M | -0.59% | 376,723 | - |
| 168 | KROS | Keros Therapeutics, Inc. | 638.47M | 3.35% | 475,963 | 232.84M |
| 169 | RLAY | Relay Therapeutics, Inc. | 631.03M | 1.95% | 1,029,187 | 8.36M |
| 170 | RZLT | Rezolute, Inc. | 623.76M | 0.70% | 957,035 | - |
| 171 | DNA | Ginkgo Bioworks Holdings, Inc. | 610.79M | -13.02% | 2,739,904 | 230.82M |
| 172 | XNCR | Xencor, Inc. | 606.96M | 4.67% | 784,028 | 146.93M |
| 173 | TRML | Tourmaline Bio, Inc. | 605.57M | 0.73% | 139,012 | - |
| 174 | MRVI | Maravai LifeSciences Holdings, Inc. | 605.21M | -2.07% | 1,132,532 | 219.83M |
| 175 | ORKA | Oruka Therapeutics, Inc. | 597.34M | 7.77% | 243,254 | - |
| 176 | RAPP | Rapport Therapeutics, Inc. | 596.38M | -7.32% | 528,337 | - |
| 177 | GOSS | Gossamer Bio, Inc. | 588.92M | 4.86% | 7,656,361 | 40.24M |
| 178 | CMPX | Compass Therapeutics, Inc. | 588.49M | -1.72% | 1,300,542 | 850.00K |
| 179 | MGTX | MeiraGTx Holdings plc | 588.07M | 0.14% | 277,503 | 37.92M |
| 180 | PVLA | Palvella Therapeutics, Inc. | 583.95M | -2.49% | 88,602 | - |
| 181 | ARVN | Arvinas, Inc. | 580.00M | 2.13% | 1,055,971 | 372.80M |
| 182 | ANAB | AnaptysBio, Inc. | 577.02M | 1.28% | 177,526 | 123.16M |
| 183 | VSTM | Verastem, Inc. | 567.45M | -0.32% | 1,814,190 | 2.14M |
| 184 | ATYR | aTyr Pharma, Inc. | 553.62M | 5.02% | 8,165,175 | 235.00K |
| 185 | NKTR | Nektar Therapeutics | 553.16M | -2.60% | 437,055 | 74.93M |
| 186 | SEPN | Septerna, Inc. | 551.52M | 2.23% | 113,968 | 726.00K |
| 187 | ZVRA | Zevra Therapeutics, Inc. | 510.83M | 0.33% | 1,037,986 | 62.02M |
| 188 | IMAB | I-Mab | 502.52M | 5.05% | 1,033,651 | 569.46K |
| 189 | BCYC | Bicycle Therapeutics plc | 499.01M | -2.44% | 167,947 | 19.28M |
| 190 | MBX | MBX Biosciences, Inc. | 489.46M | -3.45% | 368,120 | - |
| 191 | ALMS | Alumis Inc. | 489.10M | 1.29% | 663,129 | 20.06M |
| 192 | OPT | Opthea Limited | 466.57M | - | - | 146.00K |
| 193 | RGNX | REGENXBIO Inc. | 460.69M | 2.13% | 406,726 | 155.78M |
| 194 | REPL | Replimune Group, Inc. | 460.53M | 9.26% | 3,909,668 | - |
| 195 | KOD | Kodiak Sciences Inc. | 454.31M | -4.65% | 621,168 | - |
| 196 | ERAS | Erasca, Inc. | 453.87M | 1.91% | 678,687 | - |
| 197 | ARCT | Arcturus Therapeutics Holdings Inc. | 453.48M | -1.82% | 310,211 | 122.12M |
| 198 | ITOS | iTeos Therapeutics, Inc. | 448.68M | - | - | 35.00M |
| 199 | PRTA | Prothena Corporation plc | 445.17M | 0.85% | 1,048,908 | 10.34M |
| 200 | OLMA | Olema Pharmaceuticals, Inc. | 444.06M | 18.50% | 1,389,964 | - |
| 201 | CGEM | Cullinan Therapeutics, Inc. | 442.47M | -0.66% | 336,130 | - |
| 202 | ETHZ | ETHZilla Corporation | 441.83M | -4.98% | 10,421,783 | - |
| 203 | SLDB | Solid Biosciences Inc. | 422.83M | -0.91% | 760,816 | - |
| 204 | CRVS | Corvus Pharmaceuticals, Inc. | 422.49M | -1.22% | 590,197 | - |
| 205 | XOMA | XOMA Royalty Corporation | 420.17M | 6.25% | 69,612 | 44.95M |
| 206 | PRME | Prime Medicine, Inc. | 409.04M | -3.70% | 3,105,667 | 4.96M |
| 207 | LXRX | Lexicon Pharmaceuticals, Inc. | 407.01M | 1.82% | 3,336,828 | 58.43M |
| 208 | NBTX | Nanobiotix S.A. | 406.47M | -5.87% | 8,929 | -7.44M |
| 209 | INBX | Inhibrx Biosciences, Inc. | 402.26M | -1.52% | 84,223 | 1.40M |
| 210 | AURA | Aura Biosciences, Inc. | 391.98M | 0.80% | 139,860 | - |
| 211 | YMAB | Y-mAbs Therapeutics, Inc. | 388.95M | 0.12% | 549,586 | 85.39M |
| 212 | AUTL | Autolus Therapeutics plc | 375.26M | -6.00% | 7,668,564 | 29.93M |
| 213 | PRTC | PureTech Health plc | 374.81M | -6.15% | 8,025 | 6.39M |
| 214 | ASMB | Assembly Biosciences, Inc. | 374.30M | -2.61% | 135,226 | 33.25M |
| 215 | ATXS | Astria Therapeutics, Inc. | 371.91M | 6.63% | 330,188 | - |
| 216 | BNTC | Benitec Biopharma Inc. | 360.42M | 3.70% | 47,249 | - |
| 217 | ABEO | Abeona Therapeutics Inc. | 351.00M | 0.22% | 526,868 | 400.00K |
| 218 | ABSI | Absci Corporation | 349.88M | -2.09% | 2,984,453 | 4.14M |
| 219 | RCKT | Rocket Pharmaceuticals, Inc. | 349.61M | -1.22% | 1,710,449 | - |
| 220 | ADCT | ADC Therapeutics SA | 348.75M | 0.98% | 592,455 | 77.25M |
| 221 | FULC | Fulcrum Therapeutics, Inc. | 346.19M | -1.23% | 327,757 | 80.00M |
| 222 | ALDX | Aldeyra Therapeutics, Inc. | 344.40M | -1.54% | 452,092 | - |
| 223 | CTMX | CytomX Therapeutics, Inc. | 343.02M | 1.96% | 1,286,464 | 141.10M |
| 224 | ALT | Altimmune, Inc. | 330.96M | -2.09% | 2,600,789 | 20.00K |
| 225 | DSGN | Design Therapeutics, Inc. | 328.02M | 4.16% | 140,076 | - |
| 226 | CADL | Candel Therapeutics, Inc. | 321.69M | 1.21% | 444,027 | - |
| 227 | OCGN | Ocugen, Inc. | 321.67M | 0.98% | 1,631,524 | 4.75M |
| 228 | LRMR | Larimar Therapeutics, Inc. | 317.54M | 2.49% | 1,746,056 | - |
| 229 | CTNM | Contineum Therapeutics, Inc. | 313.23M | 6.89% | 202,655 | - |
| 230 | TECX | Tectonic Therapeutic, Inc. | 311.56M | -34.81% | 2,521,131 | - |
| 231 | GLUE | Monte Rosa Therapeutics, Inc. | 303.86M | 2.50% | 511,787 | 177.99M |
| 232 | FHTX | Foghorn Therapeutics Inc. | 298.48M | 4.35% | 116,452 | 24.17M |
| 233 | DRTS | Alpha Tau Medical Ltd. | 295.95M | 1.75% | 108,618 | - |
| 234 | SCPH | scPharmaceuticals Inc. | 295.77M | 0.18% | 2,531,728 | 49.97M |
| 235 | OMER | Omeros Corporation | 291.96M | 3.12% | 781,425 | - |
| 236 | CAPR | Capricor Therapeutics, Inc. | 289.39M | 0.80% | 1,018,488 | 13.39M |
| 237 | FDMT | 4D Molecular Therapeutics, Inc. | 286.75M | -0.32% | 461,340 | 33.00K |
| 238 | GALT | Galectin Therapeutics Inc. | 283.15M | 3.27% | 276,191 | - |
| 239 | NGNE | Neurogene Inc. | 282.16M | 6.98% | 56,618 | 925.00K |
| 240 | NMRA | Neumora Therapeutics, Inc. | 281.79M | 0.58% | 377,353 | - |
| 241 | MREO | Mereo BioPharma Group plc | 281.60M | 3.51% | 1,093,878 | 500.00K |
| 242 | VNDA | Vanda Pharmaceuticals Inc. | 279.49M | - | 691,597 | 203.47M |
| 243 | LCTX | Lineage Cell Therapeutics, Inc. | 278.59M | 4.27% | 2,571,733 | 10.91M |
| 244 | TVRD | Tvardi Therapeutics, Inc. | 277.38M | -1.14% | 16,936 | - |
| 245 | DRUG | Bright Minds Biosciences Inc. | 277.38M | -0.23% | 32,787 | - |
| 246 | DMAC | DiaMedica Therapeutics Inc. | 274.99M | -6.83% | 455,597 | - |
| 247 | AVIR | Atea Pharmaceuticals, Inc. | 269.82M | 1.19% | 149,358 | - |
| 248 | CBIO | Crescent Biopharma, Inc. | 267.44M | -5.00% | 109,846 | - |
| 249 | ALEC | Alector, Inc. | 262.14M | 10.21% | 1,749,934 | 81.13M |
| 250 | LXEO | Lexeo Therapeutics, Inc. | 258.65M | - | 283,466 | - |
| 251 | VOR | Vor Biopharma Inc. | 258.43M | 3.55% | 3,996,629 | - |
| 252 | PBYI | Puma Biotechnology, Inc. | 257.39M | 1.39% | 817,669 | 238.06M |
| 253 | RNAC | Cartesian Therapeutics, Inc. | 255.86M | -2.09% | 74,069 | 1.03M |
| 254 | FENC | Fennec Pharmaceuticals Inc. | 249.09M | 0.90% | 35,010 | 33.30M |
| 255 | JBIO | Jade Biosciences, Inc. | 248.62M | -3.54% | 76,903 | - |
| 256 | ALLO | Allogene Therapeutics, Inc. | 248.51M | -0.88% | 3,281,169 | 22.00K |
| 257 | DBVT | DBV Technologies S.A. | 244.63M | -4.87% | 23,759 | 3.80M |
| 258 | ENGN | enGene Holdings Inc. | 243.77M | 3.25% | 94,010 | - |
| 259 | TNXP | Tonix Pharmaceuticals Holding Corp. | 242.46M | -6.65% | 935,773 | 9.83M |
| 260 | PRQR | ProQR Therapeutics N.V. | 241.24M | 1.78% | 446,805 | 20.13M |
| 261 | SGMT | Sagimet Biosciences Inc. | 239.36M | -2.00% | 361,172 | - |
| 262 | HUMA | Humacyte, Inc. | 239.14M | -2.58% | 2,143,654 | 818.00K |
| 263 | TENX | Tenax Therapeutics, Inc. | 238.94M | -0.25% | 4,454 | - |
| 264 | IMMP | Immutep Limited | 234.41M | 1.86% | 77,065 | 3.31M |
| 265 | ANNX | Annexon, Inc. | 227.47M | 0.49% | 1,651,760 | - |
| 266 | CDXS | Codexis, Inc. | 226.57M | -8.06% | 1,568,646 | 57.16M |
| 267 | SLN | Silence Therapeutics plc | 225.31M | -0.83% | 26,206 | 27.17M |
| 268 | EDIT | Editas Medicine, Inc. | 222.10M | -3.89% | 1,306,974 | 38.90M |
| 269 | LYEL | Lyell Immunopharma, Inc. | 219.20M | 2.98% | 25,781 | 60.00K |
| 270 | ACIU | AC Immune SA | 218.66M | 8.33% | 340,620 | 36.36M |
| 271 | IMRX | Immuneering Corporation | 217.55M | 4.17% | 879,509 | - |
| 272 | ACRS | Aclaris Therapeutics, Inc. | 215.58M | 3.11% | 949,321 | 16.79M |
| 273 | CGTX | Cognition Therapeutics, Inc. | 214.38M | - | 3,633,205 | - |
| 274 | MNPR | Monopar Therapeutics Inc. | 209.22M | -0.70% | 32,040 | - |
| 275 | KRRO | Korro Bio, Inc. | 208.53M | -3.79% | 248,265 | 6.28M |
| 276 | TLSA | Tiziana Life Sciences Ltd | 202.86M | 0.55% | 104,397 | - |
| 277 | HRTX | Heron Therapeutics, Inc. | 202.35M | -2.22% | 1,008,147 | 149.69M |
| 278 | IVVD | Invivyd, Inc. | 200.80M | 5.86% | 5,365,995 | 46.21M |
| 279 | VYGR | Voyager Therapeutics, Inc. | 198.58M | 6.55% | 740,734 | 42.58M |
| 280 | IPHA | Innate Pharma S.A. | 198.17M | -3.24% | 9,975 | 20.83M |
| 281 | TIL | Instil Bio, Inc. | 197.26M | 8.22% | 107,363 | - |
| 282 | FBRX | Forte Biosciences, Inc. | 197.05M | -0.86% | 59,219 | - |
| 283 | RAPT | RAPT Therapeutics, Inc. | 196.30M | 4.31% | 34,459 | - |
| 284 | EPRX | Eupraxia Pharmaceuticals Inc. | 195.58M | 0.93% | 20,005 | - |
| 285 | GNFT | Genfit S.A. | 195.09M | -3.75% | 1,430 | 73.19M |
| 286 | OABI | OmniAb, Inc. | 193.87M | -1.25% | 233,268 | 23.03M |
| 287 | SLS | SELLAS Life Sciences Group, Inc. | 192.69M | -4.69% | 1,896,407 | - |
| 288 | ENTA | Enanta Pharmaceuticals, Inc. | 192.40M | 7.14% | 414,753 | 64.81M |
| 289 | AARD | Aardvark Therapeutics, Inc. | 192.23M | 6.75% | 247,072 | - |
| 290 | TRDA | Entrada Therapeutics, Inc. | 191.45M | -1.55% | 284,862 | 79.48M |
| 291 | CLLS | Cellectis S.A. | 186.38M | -0.89% | 59,692 | 63.44M |
| 292 | MDWD | MediWound Ltd. | 180.54M | -0.60% | 129,884 | 19.86M |
| 293 | ACTU | Actuate Therapeutics, Inc. | 180.48M | 3.08% | 89,748 | - |
| 294 | MIST | Milestone Pharmaceuticals Inc. | 180.14M | - | 1,142,392 | - |
| 295 | CCCC | C4 Therapeutics, Inc. | 178.64M | -3.46% | 697,558 | 34.24M |
| 296 | TNYA | Tenaya Therapeutics, Inc. | 176.01M | -4.42% | 2,342,560 | - |
| 297 | CRBU | Caribou Biosciences, Inc. | 175.07M | 0.53% | 499,945 | 9.12M |
| 298 | TVGN | Tevogen Bio Holdings Inc. | 175.07M | -2.20% | 470,640 | - |
| 299 | VTYX | Ventyx Biosciences, Inc. | 175.06M | 2.29% | 463,276 | - |
| 300 | MCRB | Seres Therapeutics, Inc. | 170.41M | 2.77% | 95,779 | - |
| 301 | ELTX | Elicio Therapeutics, Inc. | 168.79M | -1.80% | 98,868 | - |
| 302 | SGMO | Sangamo Therapeutics, Inc. | 162.74M | 3.73% | 3,707,388 | 81.71M |
| 303 | CURX | Curanex Pharmaceuticals Inc | 162.62M | 4.64% | 4,526,893 | - |
| 304 | NVCT | Nuvectis Pharma, Inc. | 162.41M | -3.05% | 115,302 | - |
| 305 | BDTX | Black Diamond Therapeutics, Inc. | 159.42M | 1.82% | 744,130 | 70.00M |
| 306 | MEIP | MEI Pharma, Inc. | 159.26M | -0.21% | 297,263 | - |
| 307 | GLSI | Greenwich LifeSciences, Inc. | 156.20M | -0.17% | 19,050 | - |
| 308 | KYTX | Kyverna Therapeutics, Inc. | 155.25M | -3.23% | 201,962 | - |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 152.70M | -1.54% | 416,230 | - |
| 310 | CLYM | Climb Bio, Inc. | 151.11M | - | 323,223 | - |
| 311 | IMA | ImageneBio, Inc. | 149.39M | -0.30% | 13,826 | 4.30M |
| 312 | ACHV | Achieve Life Sciences, Inc. | 149.23M | -2.01% | 1,412,410 | - |
| 313 | NKTX | Nkarta, Inc. | 149.15M | - | 375,091 | - |
| 314 | THTX | Theratechnologies Inc. | 148.88M | 0.15% | 251,460 | 84.38M |
| 315 | OBIO | Orchestra BioMed Holdings, Inc. | 147.84M | 0.55% | 119,174 | 2.94M |
| 316 | CYBN | Cybin Inc. | 147.26M | -16.58% | 1,764,279 | - |
| 317 | CHRS | Coherus Oncology, Inc. | 138.31M | 2.59% | 965,030 | 272.21M |
| 318 | INO | Inovio Pharmaceuticals, Inc. | 136.58M | 8.44% | 3,188,169 | 182.34K |
| 319 | NTHI | NeOnc Technologies Holdings, Inc. | 135.65M | -4.52% | 48,893 | 59.99K |
| 320 | CGEN | Compugen Ltd. | 133.76M | - | 174,201 | 22.14M |
| 321 | CABA | Cabaletta Bio, Inc. | 132.62M | - | 1,000,692 | - |
| 322 | AGEN | Agenus Inc. | 132.55M | -0.48% | 402,503 | 101.71M |
| 323 | VTVT | vTv Therapeutics Inc. | 131.84M | 13.30% | 20,944 | 17.00K |
| 324 | ACOG | Alpha Cognition Inc. | 131.71M | -1.81% | 28,746 | 4.59M |
| 325 | MOLN | Molecular Partners AG | 131.35M | 1.33% | 2,771 | 856.30K |
| 326 | ZURA | Zura Bio Limited | 131.34M | -0.98% | 160,313 | - |
| 327 | IKT | Inhibikase Therapeutics, Inc. | 131.15M | -2.22% | 88,230 | 1.00 |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 130.76M | 5.81% | 708,498 | 61.95M |
| 329 | CRDF | Cardiff Oncology, Inc. | 129.73M | -7.14% | 2,737,511 | 545.00K |
| 330 | HURA | TuHURA Biosciences, Inc. | 129.62M | -4.07% | 230,308 | - |
| 331 | GNLX | Genelux Corporation | 125.84M | 1.20% | 114,477 | 8.00K |
| 332 | ZNTL | Zentalis Pharmaceuticals, Inc. | 124.07M | 1.78% | 581,559 | 26.87M |
| 333 | TARA | Protara Therapeutics, Inc. | 122.30M | 1.60% | 95,694 | - |
| 334 | BMEA | Biomea Fusion, Inc. | 120.80M | 4.10% | 871,667 | - |
| 335 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 119.37M | 3.95% | 89,851 | - |
| 336 | SEER | Seer, Inc. | 119.29M | -0.98% | 60,828 | 16.29M |
| 337 | FATE | Fate Therapeutics, Inc. | 118.79M | -0.96% | 1,115,174 | 8.47M |
| 338 | AVTX | Avalo Therapeutics, Inc. | 118.63M | -2.91% | 266,339 | 441.00K |
| 339 | IFRX | InflaRx N.V. | 118.56M | 9.37% | 2,588,302 | 191.22K |
| 340 | CNTB | Connect Biopharma Holdings Limited | 117.57M | 2.43% | 213,785 | 1.97M |
| 341 | ONCY | Oncolytics Biotech Inc. | 115.42M | 10.58% | 1,182,113 | - |
| 342 | SPRO | Spero Therapeutics, Inc. | 115.36M | -0.97% | 417,016 | 48.58M |
| 343 | IOBT | IO Biotech, Inc. | 110.02M | 5.70% | 1,062,841 | - |
| 344 | MGNX | MacroGenics, Inc. | 109.98M | -1.69% | 1,534,429 | 165.50M |
| 345 | SAVA | Cassava Sciences, Inc. | 109.66M | -0.44% | 582,646 | - |
| 346 | COYA | Coya Therapeutics, Inc. | 108.71M | -0.91% | 49,484 | 423.45K |
| 347 | VTGN | Vistagen Therapeutics, Inc. | 108.00M | 5.39% | 679,115 | 646.00K |
| 348 | SRZN | Surrozen, Inc. | 105.07M | 0.62% | 5,187 | 12.62M |
| 349 | ANRO | Alto Neuroscience, Inc. | 105.06M | 5.43% | 103,430 | - |
| 350 | SKYE | Skye Bioscience, Inc. | 104.74M | -3.43% | 244,544 | - |
| 351 | HLVX | HilleVax, Inc. | 102.95M | -0.48% | 376,781 | - |
| 352 | PLRX | Pliant Therapeutics, Inc. | 102.83M | 2.13% | 392,761 | - |
| 353 | EQ | Equillium, Inc. | 102.35M | -1.15% | 811,566 | 16.55M |
| 354 | ANEB | Anebulo Pharmaceuticals, Inc. | 101.89M | -0.80% | 13,990 | - |
| 355 | ADAG | Adagene Inc. | 99.92M | -0.47% | 16,979 | 103.20K |
| 356 | ANIX | Anixa Biosciences, Inc. | 99.53M | 3.34% | 88,019 | - |
| 357 | TCRX | TScan Therapeutics, Inc. | 99.31M | -2.78% | 148,922 | 6.96M |
| 358 | ATOS | Atossa Therapeutics, Inc. | 98.89M | 0.35% | 377,737 | - |
| 359 | CSBR | Champions Oncology, Inc. | 97.35M | 3.82% | 9,087 | 56.94M |
| 360 | CVM | CEL-SCI Corporation | 97.20M | 16.59% | 421,856 | - |
| 361 | CRVO | CervoMed Inc. | 93.41M | 4.94% | 84,724 | 7.78M |
| 362 | ARMP | Armata Pharmaceuticals, Inc. | 92.39M | 2.00% | 6,981 | 6.87M |
| 363 | XBIT | XBiotech Inc. | 92.07M | -4.43% | 84,951 | - |
| 364 | ENTX | Entera Bio Ltd. | 90.87M | 3.11% | 84,603 | 166.00K |
| 365 | IPA | ImmunoPrecise Antibodies Ltd. | 89.08M | -18.57% | 3,081,353 | 17.74M |
| 366 | FBIO | Fortress Biotech, Inc. | 88.67M | 15.50% | 2,348,414 | 59.30M |
| 367 | ORMP | Oramed Pharmaceuticals Inc. | 88.16M | -2.27% | 101,912 | 2.00M |
| 368 | OVID | Ovid Therapeutics Inc. | 87.46M | -3.91% | 1,041,546 | 6.65M |
| 369 | OKYO | OKYO Pharma Limited | 87.26M | -1.28% | 55,929 | - |
| 370 | ATRA | Atara Biotherapeutics, Inc. | 86.67M | 2.41% | 68,506 | 188.67M |
| 371 | VXRT | Vaxart, Inc. | 86.46M | -2.95% | 593,434 | 80.72M |
| 372 | QNCX | Quince Therapeutics, Inc. | 85.94M | - | 65,621 | - |
| 373 | WHWK | Whitehawk Therapeutics, Inc. | 85.77M | 1.11% | 58,711 | 21.60M |
| 374 | KALA | KALA BIO, Inc. | 85.59M | 8.65% | 432,159 | - |
| 375 | NAUT | Nautilus Biotechnology, Inc. | 84.90M | -1.15% | 67,260 | - |
| 376 | PYXS | Pyxis Oncology, Inc. | 82.48M | 3.91% | 210,863 | 2.82M |
| 377 | ABOS | Acumen Pharmaceuticals, Inc. | 82.38M | - | 116,399 | - |
| 378 | STRO | Sutro Biopharma, Inc. | 80.62M | 10.96% | 1,156,112 | 104.47M |
| 379 | EXOZ | eXoZymes, Inc. | 80.10M | -1.55% | 4,746 | -700.00 |
| 380 | PMVP | PMV Pharmaceuticals, Inc. | 78.96M | 6.43% | 577,342 | - |
| 381 | IMUX | Immunic, Inc. | 78.82M | -2.56% | 1,867,876 | - |
| 382 | ATHE | Alterity Therapeutics Limited | 78.03M | 3.64% | 32,761 | 3.57M |
| 383 | XFOR | X4 Pharmaceuticals, Inc. | 77.93M | -7.59% | 674,710 | 32.77M |
| 384 | LIMN | Liminatus Pharma, Inc. | 77.78M | 10.33% | 1,360,359 | - |
| 385 | IRD | Opus Genetics, Inc. | 77.55M | 0.82% | 590,012 | 15.42M |
| 386 | UNCY | Unicycive Therapeutics, Inc. | 76.30M | 3.10% | 371,444 | - |
| 387 | CNTX | Context Therapeutics Inc. | 76.23M | 1.17% | 102,213 | - |
| 388 | ARTV | Artiva Biotherapeutics, Inc. | 75.48M | -1.90% | 44,461 | 251.00K |
| 389 | APLT | Applied Therapeutics, Inc. | 74.90M | 5.56% | 983,343 | 121.00K |
| 390 | KLRS | Kalaris Therapeutics, Inc. | 74.81M | -1.96% | 60,755 | - |
| 391 | BYSI | BeyondSpring Inc. | 73.81M | 6.98% | 34,735 | 1.88M |
| 392 | RPTX | Repare Therapeutics Inc. | 73.03M | 1.80% | 199,533 | 250.00K |
| 393 | NSRX | Nasus Pharma Ltd. | 72.84M | -0.74% | 19,975 | - |
| 394 | CBUS | Cibus, Inc. | 71.59M | -1.49% | 62,620 | 4.85M |
| 395 | OSTX | OS Therapies Incorporated | 70.80M | -7.11% | 872,567 | - |
| 396 | VANI | Vivani Medical, Inc. | 68.72M | 0.87% | 53,658 | - |
| 397 | NTRB | Nutriband Inc. | 68.67M | -4.64% | 51,319 | 2.40M |
| 398 | PTHS | Pelthos Therapeutics Inc. | 68.33M | -5.04% | 4,723 | - |
| 399 | MGX | Metagenomi, Inc. | 68.31M | 4.60% | 192,163 | 33.77M |
| 400 | CELU | Celularity Inc. | 68.06M | -35.28% | 864,024 | 44.59M |
| 401 | GUTS | Fractyl Health, Inc. | 67.72M | 0.57% | 381,358 | 17.00K |
| 402 | IMMX | Immix Biopharma, Inc. | 66.32M | 3.60% | 76,071 | - |
| 403 | GANX | Gain Therapeutics, Inc. | 66.03M | -4.02% | 667,361 | - |
| 404 | SLGL | Sol-Gel Technologies Ltd. | 66.02M | 3.99% | 8,799 | 23.93M |
| 405 | ANL | Adlai Nortye Ltd. | 65.68M | 5.33% | 5,121 | 1.94M |
| 406 | ALGS | Aligos Therapeutics, Inc. | 65.33M | 0.66% | 44,425 | 3.17M |
| 407 | QNTM | Quantum BioPharma Ltd. | 65.03M | -3.23% | 98,635 | - |
| 408 | GNTA | Genenta Science S.p.A. | 64.50M | -5.41% | 17,836 | - |
| 409 | MNOV | MediciNova, Inc. | 64.25M | - | 20,726 | 134.60K |
| 410 | PRLD | Prelude Therapeutics Incorporated | 63.96M | -6.61% | 74,518 | 7.00M |
| 411 | ADVM | Adverum Biotechnologies, Inc. | 63.79M | -1.30% | 34,477 | 1.00M |
| 412 | INKT | MiNK Therapeutics, Inc. | 62.69M | -2.67% | 37,746 | - |
| 413 | COEP | Coeptis Therapeutics Holdings, Inc. | 62.37M | -2.93% | 32,254 | 263.56K |
| 414 | ABVC | ABVC BioPharma, Inc. | 62.27M | -3.53% | 126,078 | 391.24K |
| 415 | NRXP | NRx Pharmaceuticals, Inc. | 61.80M | 12.07% | 650,460 | - |
| 416 | ACET | Adicet Bio, Inc. | 61.14M | 2.00% | 282,945 | - |
| 417 | CUE | Cue Biopharma, Inc. | 60.94M | 1.64% | 62,269 | 8.29M |
| 418 | HOWL | Werewolf Therapeutics, Inc. | 59.45M | -0.76% | 120,939 | 1.14M |
| 419 | DTIL | Precision BioSciences, Inc. | 58.93M | 2.04% | 115,690 | 1.26M |
| 420 | KPTI | Karyopharm Therapeutics Inc. | 58.79M | -4.64% | 127,203 | 137.27M |
| 421 | PDSB | PDS Biotechnology Corporation | 58.78M | 0.81% | 352,558 | - |
| 422 | ICCC | ImmuCell Corporation | 55.90M | -3.44% | 5,571 | 28.27M |
| 423 | BTAI | BioXcel Therapeutics, Inc. | 55.32M | -6.17% | 3,103,818 | 868.00K |
| 424 | ALXO | ALX Oncology Holdings Inc. | 55.16M | -11.97% | 708,449 | - |
| 425 | SER | Serina Therapeutics, Inc. | 54.43M | -0.19% | 80,607 | 130.00K |
| 426 | ATNM | Actinium Pharmaceuticals, Inc. | 53.97M | -2.81% | 161,615 | 81.00K |
| 427 | PYPD | PolyPid Ltd. | 53.38M | 1.79% | 97,671 | - |
| 428 | RENB | Lunai Bioworks Inc. | 52.54M | -4.41% | 702,037 | - |
| 429 | INMB | INmune Bio, Inc. | 52.37M | -2.96% | 757,557 | 50.00K |
| 430 | VRCA | Verrica Pharmaceuticals Inc. | 50.53M | -4.46% | 21,627 | 14.70M |
| 431 | MAIA | MAIA Biotechnology, Inc. | 49.49M | -2.60% | 165,001 | - |
| 432 | FGEN | FibroGen, Inc. | 49.25M | 2.96% | 113,794 | 7.35M |
| 433 | STTK | Shattuck Labs, Inc. | 48.38M | 2.98% | 334,347 | 3.00M |
| 434 | VERU | Veru Inc. | 48.05M | 0.92% | 104,498 | 16.89M |
| 435 | BRNS | Barinthus Biotherapeutics plc | 47.76M | 4.73% | 28,022 | 14.97M |
| 436 | JUNS | Jupiter Neurosciences, Inc. | 47.37M | -7.48% | 135,341 | - |
| 437 | RLMD | Relmada Therapeutics, Inc. | 47.13M | 26.79% | 5,849,680 | - |
| 438 | ANVS | Annovis Bio, Inc. | 45.40M | 0.87% | 121,726 | - |
| 439 | TPST | Tempest Therapeutics, Inc. | 45.16M | 2.52% | 53,145 | - |
| 440 | JSPR | Jasper Therapeutics, Inc. | 44.86M | -1.43% | 194,351 | - |
| 441 | LTRN | Lantern Pharma Inc. | 43.52M | -1.23% | 66,105 | - |
| 442 | CALC | CalciMedica, Inc. | 43.31M | 14.81% | 407,842 | - |
| 443 | PSTV | Plus Therapeutics, Inc. | 42.43M | -6.27% | 5,221,363 | 5.32M |
| 444 | ACRV | Acrivon Therapeutics, Inc. | 42.15M | - | 78,189 | - |
| 445 | RADX | Radiopharm Theranostics Limited | 41.62M | -1.64% | 19,126 | 8.79M |
| 446 | GRCE | Grace Therapeutics, Inc. | 41.35M | -1.65% | 42,346 | - |
| 447 | LVTX | LAVA Therapeutics N.V. | 41.30M | - | 90,924 | 4.99M |
| 448 | IPSC | Century Therapeutics, Inc. | 41.10M | -3.23% | 942,884 | 114.13M |
| 449 | IGC | IGC Pharma, Inc. | 40.45M | 3.25% | 1,049,695 | 1.33M |
| 450 | GBIO | Generation Bio Co. | 40.28M | -0.33% | 55,627 | 21.23M |
| 451 | ESLA | Estrella Immunopharma, Inc. | 39.66M | 1.90% | 23,911 | - |
| 452 | RNXT | RenovoRx, Inc. | 39.58M | 12.50% | 748,731 | 662.00K |
| 453 | PEPG | PepGen Inc. | 39.36M | 3.45% | 151,038 | - |
| 454 | PLUR | Pluri Inc. | 38.97M | -6.05% | 1,577 | 1.03M |
| 455 | TELO | Telomir Pharmaceuticals, Inc. | 38.74M | -9.09% | 1,425,236 | - |
| 456 | OTLK | Outlook Therapeutics, Inc. | 38.65M | 2.22% | 7,713,824 | 1.51M |
| 457 | KLTO | Klotho Neurosciences, Inc. | 38.05M | -10.62% | 2,025,507 | - |
| 458 | OKUR | OnKure Therapeutics, Inc. | 37.48M | 0.73% | 32,790 | - |
| 459 | SNTI | Senti Biosciences, Inc. | 37.41M | -2.72% | 226,780 | - |
| 460 | XLO | Xilio Therapeutics, Inc. | 36.52M | 0.66% | 220,511 | 15.00M |
| 461 | MURA | Mural Oncology plc | 36.04M | 0.97% | 343,914 | - |
| 462 | CASI | CASI Pharmaceuticals, Inc. | 35.63M | -0.43% | 102,752 | 31.56M |
| 463 | MRSN | Mersana Therapeutics, Inc. | 35.03M | -4.10% | 51,812 | 34.77M |
| 464 | PPCB | Propanc Biopharma, Inc. | 34.84M | -9.60% | 427,699 | - |
| 465 | XCUR | Exicure, Inc. | 34.56M | -2.50% | 10,837 | 500.00K |
| 466 | DYAI | Dyadic International, Inc. | 34.44M | 4.20% | 71,027 | 4.14M |
| 467 | LSB | LakeShore Biopharma Co., Ltd | 33.86M | 2.67% | 21,075 | 84.75M |
| 468 | CLGN | CollPlant Biotechnologies Ltd. | 33.57M | 0.76% | 12,473 | 2.40M |
| 469 | RANI | Rani Therapeutics Holdings, Inc. | 33.49M | -8.65% | 876,749 | 1.20M |
| 470 | HYPD | Hyperion DeFi, Inc. | 33.23M | -2.79% | 311,650 | 44.44K |
| 471 | RNTX | Rein Therapeutics Inc. | 31.46M | -2.88% | 242,342 | - |
| 472 | CAMP | Camp4 Therapeutics Corporation | 31.45M | 2.63% | 36,562 | 3.01M |
| 473 | ANTX | AN2 Therapeutics, Inc. | 31.43M | 3.64% | 24,109 | - |
| 474 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 30.81M | 0.67% | 1,183,111 | - |
| 475 | KAPA | Kairos Pharma, Ltd. | 29.25M | 4.44% | 10,435,532 | - |
| 476 | ITRM | Iterum Therapeutics plc | 28.58M | -5.44% | 705,396 | - |
| 477 | ASBP | Aspire Biopharma Holdings, Inc. | 28.50M | 0.02% | 717,243 | - |
| 478 | KZR | Kezar Life Sciences, Inc. | 28.19M | -2.53% | 47,301 | - |
| 479 | PMN | ProMIS Neurosciences, Inc. | 27.80M | -0.61% | 277,228 | - |
| 480 | DARE | Daré Bioscience, Inc. | 26.75M | 0.50% | 79,013 | -17.70K |
| 481 | CLSD | Clearside Biomedical, Inc. | 26.62M | -7.73% | 1,135,910 | 4.17M |
| 482 | BCAB | BioAtla, Inc. | 26.30M | -1.67% | 548,119 | 11.00M |
| 483 | FBLG | FibroBiologics, Inc. | 26.03M | 5.30% | 413,241 | - |
| 484 | NRXS | NeurAxis, Inc. | 25.97M | 3.54% | 71,189 | 3.22M |
| 485 | BOLD | Boundless Bio, Inc. | 25.74M | 2.68% | 61,096 | - |
| 486 | NRSN | NeuroSense Therapeutics Ltd. | 25.59M | -1.89% | 403,389 | - |
| 487 | ICU | SeaStar Medical Holding Corporation | 25.56M | -0.04% | 1,886,477 | 766.00K |
| 488 | CVKD | Cadrenal Therapeutics, Inc. | 25.40M | -4.24% | 16,201 | - |
| 489 | ENLV | Enlivex Therapeutics Ltd. | 25.11M | 0.95% | 194,725 | - |
| 490 | THAR | Tharimmune, Inc. | 24.10M | -12.61% | 1,618,600 | - |
| 491 | RLYB | Rallybio Corporation | 23.30M | 3.89% | 301,127 | 761.00K |
| 492 | GDTC | CytoMed Therapeutics Limited | 23.14M | 0.15% | 6,834 | 368.84K |
| 493 | AKTX | Akari Therapeutics, Plc | 22.83M | -7.91% | 571,228 | - |
| 494 | PASG | Passage Bio, Inc. | 22.60M | -0.28% | 25,588 | - |
| 495 | NNVC | NanoViricides, Inc. | 22.50M | 0.72% | 70,866 | - |
| 496 | NEUP | Neuphoria Therapeutics Inc. | 22.47M | 5.47% | 71,441 | 15.66M |
| 497 | SABS | SAB Biotherapeutics, Inc. | 22.07M | 1.92% | 127,533 | 114.70K |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 21.95M | -3.01% | 321,916 | - |
| 499 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 21.64M | -2.46% | 324,898 | 1.00M |
| 500 | QTTB | Q32 Bio Inc. | 20.98M | 0.58% | 83,866 | - |
| 501 | CRIS | Curis, Inc. | 20.50M | -1.80% | 35,657 | 11.41M |
| 502 | ALLR | Allarity Therapeutics, Inc. | 20.44M | 3.90% | 3,484,610 | - |
| 503 | ABP | Abpro Holdings, Inc. | 20.21M | 2.86% | 3,055,357 | 183.00K |
| 504 | CING | Cingulate Inc. | 20.19M | -6.52% | 172,910 | - |
| 505 | LSTA | Lisata Therapeutics, Inc. | 19.35M | -4.74% | 38,659 | 1.07M |
| 506 | LIXT | Lixte Biotechnology Holdings, Inc. | 19.07M | -6.07% | 57,138 | - |
| 507 | GOVX | GeoVax Labs, Inc. | 18.76M | -0.76% | 420,305 | 6.14M |
| 508 | CARM | Carisma Therapeutics, Inc. | 18.39M | 104.65% | 375,339,580 | 10.77M |
| 509 | EVAX | Evaxion A/S | 17.53M | 0.91% | 49,696 | 3.18M |
| 510 | PULM | Pulmatrix, Inc. | 17.38M | -3.45% | 5,160 | 369.00K |
| 511 | LGVN | Longeveron Inc. | 17.31M | -0.75% | 240,801 | 2.07M |
| 512 | CYCC | Cyclacel Pharmaceuticals, Inc. | 17.22M | -6.62% | 41,396 | 10.00K |
| 513 | SYBX | Synlogic, Inc. | 17.08M | 0.69% | 17,920 | 8.00K |
| 514 | HOTH | Hoth Therapeutics, Inc. | 16.97M | 10.34% | 20,275,696 | - |
| 515 | LEXX | Lexaria Bioscience Corp. | 16.82M | -2.29% | 48,360 | 615.92K |
| 516 | EDSA | Edesa Biotech, Inc. | 16.54M | 1.29% | 15,860 | - |
| 517 | CMMB | Chemomab Therapeutics Ltd. | 16.04M | -1.27% | 82,553 | - |
| 518 | IBIO | iBio, Inc. | 15.94M | -0.81% | 489,168 | 375.00K |
| 519 | PRTG | Portage Biotech Inc. | 15.86M | -3.33% | 40,362 | - |
| 520 | BLRX | BioLineRx Ltd. | 15.85M | -1.06% | 30,041 | 17.25M |
| 521 | NERV | Minerva Neurosciences, Inc. | 15.84M | -3.39% | 17,612 | - |
| 522 | LPCN | Lipocine Inc. | 15.72M | 2.41% | 21,428 | 4.21M |
| 523 | OSRH | OSR Holdings, Inc. | 15.63M | -6.74% | 532,058 | 104.74K |
| 524 | MTVA | MetaVia Inc. | 15.41M | 1.53% | 73,085 | - |
| 525 | COCP | Cocrystal Pharma, Inc. | 15.39M | - | 46,878 | - |
| 526 | CLRB | Cellectar Biosciences, Inc. | 15.39M | -1.03% | 120,331 | - |
| 527 | ADAP | Adaptimmune Therapeutics plc | 15.32M | -1.87% | 26,231,027 | 65.09M |
| 528 | ATHA | Athira Pharma, Inc. | 15.26M | -0.41% | 125,226 | - |
| 529 | PHGE | BiomX Inc. | 14.83M | 3.58% | 423,002 | - |
| 530 | IMNN | Imunon, Inc. | 14.75M | -1.35% | 37,277 | - |
| 531 | CANF | Can-Fite BioPharma Ltd. | 13.97M | 4.88% | 181,148 | 560.00K |
| 532 | BRTX | BioRestorative Therapies, Inc. | 13.80M | -5.98% | 105,651 | 605.20K |
| 533 | BCTX | BriaCell Therapeutics Corp. | 13.66M | 9.01% | 132,224 | - |
| 534 | INTS | Intensity Therapeutics, Inc. | 13.43M | -2.48% | 1,415,041 | - |
| 535 | SNGX | Soligenix, Inc. | 13.33M | 0.32% | 225,770 | 2.34K |
| 536 | APM | Aptorum Group Limited | 13.29M | -5.58% | 344,751 | - |
| 537 | NBY | NovaBay Pharmaceuticals, Inc. | 13.28M | 28.09% | 6,594,877 | 9.78M |
| 538 | NXTC | NextCure, Inc. | 13.19M | -1.99% | 28,317 | - |
| 539 | LPTX | Leap Therapeutics, Inc. | 12.20M | 2.12% | 475,333 | - |
| 540 | LYRA | Lyra Therapeutics, Inc. | 12.19M | 5.86% | 45,816 | 770.00K |
| 541 | PHIO | Phio Pharmaceuticals Corp. | 12.14M | 7.61% | 445,340 | - |
| 542 | PLRZ | Polyrizon Ltd. | 12.08M | -1.83% | 251,301 | - |
| 543 | IMRN | Immuron Limited | 12.06M | -0.27% | 42,578 | 4.78M |
| 544 | ARTL | Artelo Biosciences, Inc. | 11.96M | -2.16% | 10,848 | - |
| 545 | BIVI | BioVie Inc. | 11.90M | 3.95% | 431,042 | - |
| 546 | MRKR | Marker Therapeutics, Inc. | 11.58M | -3.33% | 414,476 | 5.39M |
| 547 | MBRX | Moleculin Biotech, Inc. | 11.48M | -3.41% | 3,126,002 | - |
| 548 | BCDA | BioCardia, Inc. | 11.46M | -0.10% | 24,494 | 3.00K |
| 549 | EPIX | ESSA Pharma Inc. | 11.30M | -0.50% | 6,398,089 | - |
| 550 | MBIO | Mustang Bio, Inc. | 11.08M | 1.32% | 109,857 | - |
| 551 | XTLB | XTL Biopharmaceuticals Ltd. | 10.93M | -3.25% | 2,918 | 451.00K |
| 552 | EVGN | Evogene Ltd. | 10.86M | -1.60% | 38,319 | 9.44M |
| 553 | ERNA | Ernexa Therapeutics Inc. | 10.36M | 1.50% | 60,944 | 488.00K |
| 554 | TRAW | Traws Pharma, Inc. | 10.17M | 2.86% | 45,379 | 2.90M |
| 555 | MTNB | Matinas BioPharma Holdings, Inc. | 10.16M | 0.55% | 128,185 | - |
| 556 | INAB | IN8bio, Inc. | 10.03M | - | 26,605 | - |
| 557 | SNSE | Sensei Biotherapeutics, Inc. | 9.90M | -6.04% | 4,706 | - |
| 558 | HCWB | HCW Biologics Inc. | 9.70M | -6.47% | 106,624 | 832.84K |
| 559 | BOLT | Bolt Biotherapeutics, Inc. | 9.56M | -2.92% | 23,360 | 4.17M |
| 560 | PCSA | Processa Pharmaceuticals, Inc. | 9.47M | -0.48% | 1,300,636 | - |
| 561 | CSCI | COSCIENS Biopharma Inc. | 9.47M | 1.32% | 3,221 | 9.44M |
| 562 | KPRX | Kiora Pharmaceuticals, Inc. | 9.37M | -1.08% | 48,700 | 20.00K |
| 563 | DWTX | Dogwood Therapeutics, Inc. | 9.19M | -3.02% | 2,554 | - |
| 564 | APRE | Aprea Therapeutics, Inc. | 9.15M | 0.32% | 17,379 | 841.01K |
| 565 | CERO | CERo Therapeutics Holdings, Inc. | 8.93M | -1.46% | 14,680 | - |
| 566 | KZIA | Kazia Therapeutics Limited | 8.71M | -3.47% | 72,923 | 1.55M |
| 567 | AEON | AEON Biopharma, Inc. | 8.65M | 1.54% | 28,660 | - |
| 568 | RNAZ | TransCode Therapeutics, Inc. | 8.58M | 5.76% | 8,999 | - |
| 569 | CELZ | Creative Medical Technology Holdings, Inc. | 8.28M | 0.94% | 7,856 | 6.00K |
| 570 | ADIL | Adial Pharmaceuticals, Inc. | 8.22M | -0.87% | 256,648 | - |
| 571 | VYNE | VYNE Therapeutics Inc. | 8.21M | 0.62% | 2,577,430 | 476.00K |
| 572 | CYCN | Cyclerion Therapeutics, Inc. | 8.01M | 1.21% | 8,180 | 2.17M |
| 573 | ALZN | Alzamend Neuro, Inc. | 7.60M | -0.82% | 65,004 | - |
| 574 | IBO | Impact BioMedical Inc. | 7.31M | 3.47% | 103,443 | 7.00K |
| 575 | GLMD | Galmed Pharmaceuticals Ltd. | 6.94M | - | 79,050 | - |
| 576 | ACXP | Acurx Pharmaceuticals, Inc. | 6.91M | -5.63% | 64,383 | - |
| 577 | ADXN | Addex Therapeutics Ltd | 6.86M | 2.41% | 743 | 278.51K |
| 578 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.86M | 2.10% | 17,353 | 19.51K |
| 579 | INDP | Indaptus Therapeutics, Inc. | 6.72M | -6.62% | 8,530 | - |
| 580 | TNFA | TNF Pharmaceuticals, Inc. | 6.71M | -21.33% | 1,244,431 | - |
| 581 | KTTA | Pasithea Therapeutics Corp. | 6.69M | 11.20% | 567,292 | - |
| 582 | NLSP | NLS Pharmaceutics AG | 6.51M | -2.83% | 68,527 | - |
| 583 | CLDI | Calidi Biotherapeutics, Inc. | 6.40M | - | 255,806 | - |
| 584 | PMCB | PharmaCyte Biotech, Inc. | 6.33M | -0.80% | 75,794 | - |
| 585 | ENSC | Ensysce Biosciences, Inc. | 6.20M | - | 44,515 | 7.41M |
| 586 | VIVS | VivoSim Labs, Inc. | 6.08M | -4.10% | 558,330 | 142.00K |
| 587 | SILO | Silo Pharma, Inc. | 6.05M | 1.81% | 76,030 | 72.10K |
| 588 | PALI | Palisade Bio, Inc. | 6.04M | -2.04% | 220,961 | - |
| 589 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 5.83M | 0.71% | 125,719 | 984.49K |
| 590 | NCNA | NuCana plc | 5.69M | -6.58% | 285,198 | - |
| 591 | PPBT | Purple Biotech Ltd | 5.59M | -28.64% | 468,955 | - |
| 592 | CMND | Clearmind Medicine Inc. | 5.34M | -1.42% | 44,000 | - |
| 593 | GNPX | Genprex, Inc. | 5.29M | -3.54% | 1,774,647 | - |
| 594 | APVO | Aptevo Therapeutics Inc. | 5.26M | -2.44% | 109,312 | - |
| 595 | ADTX | Aditxt, Inc. | 5.18M | 0.97% | 130,163 | 12.05K |
| 596 | TCRT | Alaunos Therapeutics, Inc. | 5.10M | 8.45% | 82,561 | 6.00K |
| 597 | MLEC | Moolec Science SA | 5.06M | -3.89% | 121,655 | 7.83M |
| 598 | TTNP | Titan Pharmaceuticals, Inc. | 4.84M | -8.08% | 21,798 | - |
| 599 | APLM | Apollomics, Inc. | 4.65M | 7.08% | 11,817 | 198.00K |
| 600 | REVB | Revelation Biosciences, Inc. | 4.59M | -2.17% | 47,641 | - |
| 601 | XBIO | Xenetic Biosciences, Inc. | 4.55M | 3.51% | 23,563 | 2.45M |
| 602 | ONCO | Onconetix, Inc. | 4.53M | - | 17,042 | 1.33M |
| 603 | QNRX | Quoin Pharmaceuticals, Ltd. | 4.47M | 3.05% | 1,105 | - |
| 604 | ENTO | Entero Therapeutics, Inc. | 4.35M | 20.44% | 375,910 | - |
| 605 | OGEN | Oragenics, Inc. | 4.33M | 1.94% | 152,311 | - |
| 606 | XRTX | XORTX Therapeutics Inc. | 4.18M | 1.94% | 17,578 | - |
| 607 | CDT | CDT Equity Inc. | 4.07M | - | 69,831 | - |
| 608 | SLXN | Silexion Therapeutics Corp | 4.05M | -1.09% | 9,481 | - |
| 609 | DRMA | Dermata Therapeutics, Inc. | 3.98M | 1.74% | 9,189 | - |
| 610 | GLTO | Galecto, Inc. | 3.97M | -5.66% | 23,154 | - |
| 611 | TOVX | Theriva Biologics, Inc. | 3.91M | -0.54% | 171,160 | - |
| 612 | JAGX | Jaguar Health, Inc. | 3.63M | 2.45% | 120,393 | 11.81M |
| 613 | CNSP | CNS Pharmaceuticals, Inc. | 3.59M | 0.81% | 6,382 | - |
| 614 | ENVB | Enveric Biosciences, Inc. | 3.54M | -3.54% | 258,748 | - |
| 615 | GRI | GRI Bio, Inc. | 3.52M | 0.72% | 36,192 | - |
| 616 | AZTR | Azitra, Inc. | 3.43M | -9.16% | 684,207 | 7.50K |
| 617 | BDRX | Biodexa Pharmaceuticals Plc | 3.32M | -3.25% | 11,029 | 104.90K |
| 618 | GTBP | GT Biopharma, Inc. | 3.20M | -3.78% | 150,408 | - |
| 619 | PTIX | Protagenic Therapeutics, Inc. | 3.12M | -0.28% | 107,354 | - |
| 620 | QLGN | Qualigen Therapeutics, Inc. | 3.03M | -1.12% | 17,269 | - |
| 621 | SLRX | Salarius Pharmaceuticals, Inc. | 2.53M | -13.72% | 74,922 | - |
| 622 | VRAX | Virax Biolabs Group Limited | 2.48M | -5.73% | 155,043 | 6.33K |
| 623 | ELAB | PMGC Holdings Inc. | 1.98M | -17.81% | 142,210 | -605.53K |
| 624 | PBM | Psyence Biomedical Ltd. | 1.64M | 0.36% | 57,779 | - |
| 625 | SCNI | Scinai Immunotherapeutics Ltd. | 1.44M | 0.65% | 120,025 | 658.00K |
| 626 | SPRC | SciSparc Ltd. | 1.30M | -0.81% | 298,291 | 1.31M |